Matching slides 118,471
Current window 92,131-92,160
Pages 3,950
Rows per page 30
Component: Paragraphclear collectionreset all

Component

92,131-92,160 of 118,471

filter-aware
03
The slide uses a split-screen layout with a dark background on the left and a high-quality photo of a researcher on the right.AbCellera | Investor Conference Presentation Deck | 25 slides · AbCellera
Conference presentation Investor relations Beat · Situation & ContextLoop · Golden Circle1 hit
06
The slide uses a timeline-like process flow to highlight the high barrier to entry in the drug discovery sector.AbCellera | Investor Conference Presentation Deck | 25 slides · AbCellera
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
11
The slide uses a contrast-pairs approach to highlight the strategic differentiation of AbCellera.AbCellera | Investor Conference Presentation Deck | 25 slides · AbCellera
Conference presentation Investor relations Beat · Evidence & Proof1 hit
12
Uses a 'No guarantees' list to emphasize risk.AbCellera | Investor Conference Presentation Deck | 25 slides · AbCellera
Conference presentation Investor relations Beat · Evidence & Proof1 hit
19
The slide highlights three specific acquisitions (OrthoMab, Trianni, TetraGenetics) and their role in enabling T cell engagers and GPCR/ion channel research.AbCellera | Investor Conference Presentation Deck | 25 slides · AbCellera
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
20
The slide uses a logo grid to establish credibility through existing partnerships.AbCellera | Investor Conference Presentation Deck | 25 slides · AbCellera
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
21
The chart uses a stacked bar approach to show revenue components over a 21-year timeline.AbCellera | Investor Conference Presentation Deck | 25 slides · AbCellera
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
22
The slide uses a radial chart to show therapeutic area distribution and a secondary donut chart for health sector classification.AbCellera | Investor Conference Presentation Deck | 25 slides · AbCellera
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
25
AbCellera | Investor Conference Presentation Deck | 25 slidesAbCellera | Investor Conference Presentation Deck | 25 slides · AbCellera
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
01
Slide 1
AbCellera | Results Presentation Deck | 14 slidesAbCellera | Results Presentation Deck | 14 slides · AbCellera
Conference presentation Investor relations Beat · Attention1 hit
03
The slide uses a background image of a scientist at a microscope to reinforce the company's focus on R&D.AbCellera | Results Presentation Deck | 14 slides · AbCellera
Conference presentation Investor relations Beat · AttentionLoop · Logic Chain1 hit
05
The slide highlights a strategic partnership expansion with specific deal terms regarding co-investment and ownership.AbCellera | Results Presentation Deck | 14 slides · AbCellera
Conference presentation Investor relations Beat · NeedLoop · Logic Chain1 hit
06
The visual shows a bispecific antibody structure connecting CD3-binding and tumor-binding arms.AbCellera | Results Presentation Deck | 14 slides · AbCellera
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
01
Slide 1
Features company logo and stylized 'a' graphic.Absci | Investor Presentation Deck | 28 slides · Absci
Pitch deck Investor relations 1 hit
05
The large circle represents the 10^10 scale, while the tiny dot represents the 10^5 scale, visually emphasizing the magnitude of the advantage.Absci | Investor Presentation Deck | 28 slides · Absci
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
06
Uses a comparison to physical reality to frame the scale of the computational problem.Absci | Investor Presentation Deck | 28 slides · Absci
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
07
Uses a simple circle diagram to represent the subset of viable monoclonal antibodies (mAbs).Absci | Investor Presentation Deck | 28 slides · Absci
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
08
Uses a simple visual metaphor of a small subset (4%) within a larger set to illustrate the low success rate.Absci | Investor Presentation Deck | 28 slides · Absci
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
09
The visual uses a Venn-like diagram to illustrate the expansion of the search space.Absci | Investor Presentation Deck | 28 slides · Absci
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
13
Absci | Investor Presentation Deck | 28 slidesAbsci | Investor Presentation Deck | 28 slides · Absci
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
15
Absci | Investor Presentation Deck | 28 slidesAbsci | Investor Presentation Deck | 28 slides · Absci
Pitch deck Investor relations 1 hit
16
The slide uses a process flow diagram to illustrate the transition from wet-lab assays to in silico prediction.Absci | Investor Presentation Deck | 28 slides · Absci
Pitch deck Investor relations Beat · Traction1 hit
20
The chart shows a stacked bar representation where USG = UPG + UVG. Q3'21 shows negative volume growth.Unilever | Results Presentation Deck | 30 slides · Unilever
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
01
Slide 1
WPP | Results Presentation Deck | 24 slidesWPP | Results Presentation Deck | 24 slides · WPP
Conference presentation Investor relations 1 hit
23
The chart visualizes debt repayment obligations over time, with color-coded bars representing different debt instruments.WPP | Results Presentation Deck | 24 slides · WPP
Conference presentation Investor relations 1 hit
01
Slide 1
Zegna | Results Presentation Deck | 37 slidesZegna | Results Presentation Deck | 37 slides · Ermenegildo Zegna Group
Conference presentation Investor relations Beat · Attention1 hit
24
Includes detailed footnotes regarding regional definitions and product line composition.Zegna | Results Presentation Deck | 37 slides · Ermenegildo Zegna Group
Conference presentation Investor relations Beat · Action1 hit
32
The table reconciles (Loss)/Profit for the year to Adjusted Profit/(Loss) attributable to shareholders, then calculates EPS.Zegna | Results Presentation Deck | 37 slides · Ermenegildo Zegna Group
Conference presentation Investor relations Beat · Action1 hit
35
Includes a specific note regarding a 2021 building purchase.Zegna | Results Presentation Deck | 37 slides · Ermenegildo Zegna Group
Conference presentation Investor relations Beat · Action1 hit
36
This slide provides the granular breakdown of adjustments used to calculate non-IFRS metrics like Adjusted EBITDA.Zegna | Results Presentation Deck | 37 slides · Ermenegildo Zegna Group
Conference presentation Investor relations Beat · Action1 hit